Last synced on 18 April 2025 at 11:05 pm

Apheresis For Focal Glomerulosclerosis In Adult And Pediatric Patients

Page Type
Product Code
Definition
Removal of plasma components to treat focal glomerulosclerosis
Physical State
Composed of four components: a pair of paheresis columns (dextran sulfate cellulose adsorption column soaked in sodium citrate solution); two other disposable components (a hollow fiber, ethylene vinyl alcohol copolymer-coated polyethylene plasma separator and a polyvinyl chloride tubing system); and a reusable electronic control unit.
Technical Method
Blood is pumped from patients arm into the device which then separates blood into cellular components and plasma. Plasma is then sent thru dextran sulfate cellulose column to remove specific plasma components. Depleted plasma is then recombined with cellular blood elements and is then pumped back to patient.
Target Area
Plasma components are removed to aid the patients kidneys
Review Panel
Gastroenterology and Urology
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code PBN to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Apheresis For Focal Glomerulosclerosis In Adult And Pediatric Patients

Page Type
Product Code
Definition
Removal of plasma components to treat focal glomerulosclerosis
Physical State
Composed of four components: a pair of paheresis columns (dextran sulfate cellulose adsorption column soaked in sodium citrate solution); two other disposable components (a hollow fiber, ethylene vinyl alcohol copolymer-coated polyethylene plasma separator and a polyvinyl chloride tubing system); and a reusable electronic control unit.
Technical Method
Blood is pumped from patients arm into the device which then separates blood into cellular components and plasma. Plasma is then sent thru dextran sulfate cellulose column to remove specific plasma components. Depleted plasma is then recombined with cellular blood elements and is then pumped back to patient.
Target Area
Plasma components are removed to aid the patients kidneys
Review Panel
Gastroenterology and Urology
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code PBN to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.